Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
RUFY2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
PDZD8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DNMT3A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DCLK2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MDM1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC35C2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EID1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RANBP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MIR4723 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GLRX3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FGFR1OP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FABP5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TUBGCP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SPC25 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PPIL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PTMA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC35F3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on